Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Stephanie Davis is an analyst at Barclays. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/02/2024 | WAY | Buy Now | Waystar Holding | $21.22 | 13.1% | → $24 | Initiates | → Overweight | Get Alert |
| 06/28/2024 | ACCD | Buy Now | Accolade | $3.51 | 56.64% | $11 → $5.5 | Maintains | Equal-Weight | Get Alert |
| 05/20/2024 | GDRX | Buy Now | GoodRx Holdings | $8.18 | 22.25% | $9 → $10 | Maintains | Overweight | Get Alert |
| 04/26/2024 | LH | Buy Now | Laboratory Corp | $203.32 | 4.76% | $234 → $213 | Maintains | Equal-Weight | Get Alert |
| 04/25/2024 | DGX | Buy Now | Quest Diagnostics | $138.92 | 3.66% | $138 → $144 | Maintains | Equal-Weight | Get Alert |
| 03/01/2024 | WW | Buy Now | WW International | $1.25 | 20.06% | $8 → $1.5 | Maintains | Underweight | Get Alert |
| 02/28/2024 | RCM | Buy Now | R1 RCM | $12.66 | 10.58% | $14 → $14 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/23/2024 | TALK | Buy Now | Talkspace | $2.21 | 35.75% | $2.5 → $3 | Maintains | Equal-Weight | Get Alert |
| 01/22/2024 | CPSI | Buy Now | CPSI | — | — | $12 → $10 | Maintains | Equal-Weight | Get Alert |
| 01/03/2024 | OPRX | Buy Now | OptimizeRx | $9.96 | 50.6% | → $15 | Initiates | → Equal-Weight | Get Alert |
| 01/03/2024 | PHR | Buy Now | Phreesia | $20.20 | 43.56% | → $29 | Initiates | → Overweight | Get Alert |
| 01/03/2024 | LH | Buy Now | Laboratory Corp | $203.32 | 9.19% | → $222 | Initiates | → Equal-Weight | Get Alert |
| 01/03/2024 | RCM | Buy Now | R1 RCM | $12.66 | 10.58% | → $14 | Initiates | → Overweight | Get Alert |
| 01/03/2024 | TALK | Buy Now | Talkspace | $2.21 | 13.12% | → $2.5 | Initiates | → Equal-Weight | Get Alert |
| 01/03/2024 | MDRX | Buy Now | Veradigm | — | — | → $11 | Initiates | → Equal-Weight | Get Alert |
| 01/03/2024 | COR | Buy Now | Cencora | $223.69 | 8.19% | → $242 | Initiates | → Overweight | Get Alert |
| 01/03/2024 | CAH | Buy Now | Cardinal Health | $96.88 | 20.77% | → $117 | Initiates | → Overweight | Get Alert |
| 02/23/2023 | TDOC | Buy Now | Teladoc Health | $9.28 | 266.38% | → $34 | Upgrade | Market Perform → Outperform | Get Alert |
| 02/08/2023 | PINC | Buy Now | Premier | $18.40 | 128.26% | $46 → $42 | Maintains | Outperform | Get Alert |
| 01/05/2023 | PHR | Buy Now | Phreesia | $20.20 | 93.07% | $34 → $39 | Maintains | Outperform | Get Alert |
| 01/05/2023 | PGNY | Buy Now | Progyny | $28.25 | 20.35% | $59 → $34 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/09/2022 | PHR | Buy Now | Phreesia | $20.20 | 68.32% | $31 → $34 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/02/2022 | VEEV | Buy Now | Veeva Sys | $182.89 | 27.4% | $242 → $233 | Maintains | Outperform | Get Alert |
| 11/09/2022 | HCAT | Buy Now | Health Catalyst | $6.22 | 173.31% | $20 → $17 | Maintains | Outperform | Get Alert |
| 11/09/2022 | TALK | Buy Now | Talkspace | $2.21 | -54.75% | $2 → $1 | Maintains | Market Perform | Get Alert |
| 11/09/2022 | RCM | Buy Now | R1 RCM | $12.66 | 26.38% | $35 → $16 | Maintains | Outperform | Get Alert |
| 10/26/2022 | NXGN | Buy Now | NextGen Healthcare | — | — | $24 → $25 | Maintains | Outperform | Get Alert |
| 10/07/2022 | ACCD | Buy Now | Accolade | $3.51 | 270.23% | $8 → $13 | Maintains | Market Perform | Get Alert |
| 09/08/2022 | PHR | Buy Now | Phreesia | $20.20 | 53.47% | $27 → $31 | Maintains | Market Perform | Get Alert |
| 09/01/2022 | VEEV | Buy Now | Veeva Sys | $182.89 | 32.32% | $268 → $242 | Maintains | Outperform | Get Alert |
| 08/09/2022 | GDRX | Buy Now | GoodRx Holdings | $8.18 | 34.47% | $8 → $11 | Maintains | Market Perform | Get Alert |
| 06/07/2022 | HQY | Buy Now | HealthEquity | $81.57 | -6.83% | $67 → $76 | Maintains | Outperform | Get Alert |
| 06/03/2022 | PHR | Buy Now | Phreesia | $20.20 | 8.91% | $29 → $22 | Maintains | Market Perform | Get Alert |
| 05/18/2022 | DOCS | Buy Now | Doximity | $27.18 | 146.5% | $72 → $67 | Maintains | Outperform | Get Alert |
| 05/11/2022 | HCAT | Buy Now | Health Catalyst | $6.22 | 253.7% | $48 → $22 | Maintains | Outperform | Get Alert |
| 05/09/2022 | TRHC | Buy Now | Tabula Rasa HealthCare | — | — | $11 → $4 | Maintains | Market Perform | Get Alert |
| 05/04/2022 | NXGN | Buy Now | NextGen Healthcare | — | — | $22 → $24 | Maintains | Outperform | Get Alert |
| 05/04/2022 | TALK | Buy Now | Talkspace | $2.21 | -9.5% | $3 → $2 | Maintains | Market Perform | Get Alert |
| 03/31/2022 | PHR | Buy Now | Phreesia | $20.20 | 43.56% | $41 → $29 | Maintains | Market Perform | Get Alert |
| 03/03/2022 | VEEV | Buy Now | Veeva Sys | $182.89 | 46.54% | $282 → $268 | Maintains | Outperform | Get Alert |
| 03/03/2022 | CPSI | Buy Now | CPSI | — | — | $35 → $38 | Maintains | Outperform | Get Alert |
| 03/03/2022 | MDRX | Buy Now | Veradigm | — | — | $22 → $24 | Maintains | Outperform | Get Alert |
| 03/02/2022 | HCAT | Buy Now | Health Catalyst | $6.22 | 671.7% | $64 → $48 | Maintains | Outperform | Get Alert |
| 03/01/2022 | GDRX | Buy Now | GoodRx Holdings | $8.18 | 303.42% | $49 → $33 | Maintains | Outperform | Get Alert |
| 02/16/2022 | CPSI | Buy Now | CPSI | — | — | $37 → $35 | Maintains | Outperform | Get Alert |
| 01/25/2022 | MDRX | Buy Now | Veradigm | — | — | $19 → $22 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/06/2022 | PHR | Buy Now | Phreesia | $20.20 | 102.97% | $57 → $41 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/06/2022 | NXGN | Buy Now | NextGen Healthcare | — | — | — | Upgrade | Market Perform → Outperform | Get Alert |
| 01/06/2022 | VEEV | Buy Now | Veeva Sys | $182.89 | — | — | Upgrade | Market Perform → Outperform | Get Alert |
| 12/21/2021 | CERN | Buy Now | Cerner | — | — | $88 → $95 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/10/2021 | PHR | Buy Now | Phreesia | $20.20 | 182.18% | — | Maintains | Outperform | Get Alert |
| 12/02/2021 | VEEV | Buy Now | Veeva Systems | $182.89 | 54.19% | — | Maintains | Market Perform | Get Alert |
| 11/19/2021 | TDOC | Buy Now | Teladoc Health | $9.28 | 1979.74% | — | Maintains | Outperform | Get Alert |
| 11/16/2021 | TALK | Buy Now | Talkspace | $2.21 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/11/2021 | GDRX | Buy Now | GoodRx Holdings | $8.18 | 499.02% | — | Maintains | Outperform | Get Alert |
